Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-06

Clinical Trial Update: Assessing the Necessity of Prescribing Antibiotics (Clavulin or Clindamycin Versus Placebo) Post-peritonsillar Abscess Drainage [NA]

View source ↗

Summary

A clinical trial evaluating whether antibiotics (Clavulin or Clindamycin) are necessary after drainage of a peritonsillar abscess has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clavulin (amoxicillin/clavulanate)
  • Clindamycin

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Peritonsillar Abscess | NA | Status: WITHDRAWN